Navamedic
NAVA | OL
Overview
Corporate Details
- ISIN(s):
- NO0010205966
- LEI:
- 529900LKVQOR2SRUJU71
- Country:
- Norway
- Address:
- Henrik Ibsens gate 100, 0255 OSLO
- Website:
- https://navamedic.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Navamedic ASA is a Nordic pharma company with a footprint in Northern Europe. We are a reliable supplier of high-quality products, delivered to hospitals and through pharmacies, meeting the specific medical needs of patients and consumers. Our product portfolio consists of prescription and OTC pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. Navamedic is present in all Nordic countries, the Baltics and Benelux and has sales of specific products even in other European countries like UK and Greece. Our headquarter is in Oslo, Norway and we are listed on the Oslo Stock Exchange (ticker: NAVA).
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-04 10:29 |
Declaration of Voting Results & Voting Rights Announcements
Navamedic ASA: Minutes of Annual General Meeting - Attachment: Navamedic_Minute…
|
Norwegian | 545.6 KB | |
| 2025-06-04 10:29 |
Declaration of Voting Results & Voting Rights Announcements
Navamedic ASA: Minutes of Annual General Meeting
|
English | 1.0 KB | |
| 2025-05-14 12:35 |
Regulatory News Service
Navamedic ASA: Notice of Annual General Meeting
|
Norwegian | 2.0 MB | |
| 2025-05-14 12:35 |
Regulatory News Service
Navamedic ASA: Notice of Annual General Meeting
|
Norwegian | 931 bytes | |
| 2025-05-05 08:56 |
Regulatory News Service
Navamedic ASA launches Eroxon® in Denmark
|
Norwegian | 4.4 KB | |
| 2025-04-30 17:42 |
Annual Report
Navamedic ASA: Annual Report 2024
|
Norwegian | 13.3 MB | |
| 2025-04-30 17:42 |
Annual Report
Navamedic ASA: Annual Report 2024
|
Norwegian | 3.9 MB | |
| 2025-04-30 17:42 |
Annual Report
Navamedic ASA: Annual Report 2024
|
Norwegian | 2.0 KB | |
| 2025-04-30 05:00 |
Regulatory News Service
Navamedic Q1 2025: Sterk start på året og godt posisjonert for fremtidig vekst
|
Norwegian | 3.9 MB | |
| 2025-04-30 05:00 |
Regulatory News Service
Navamedic Q1 2025: Strong start of the year and well-positioned for future grow…
|
English | 3.9 MB | |
| 2025-04-30 05:00 |
Regulatory News Service
Navamedic Q1 2025: Sterk start på året og godt posisjonert for fremtidig vekst
|
Norwegian | 6.4 KB | |
| 2025-04-30 05:00 |
Regulatory News Service
Navamedic Q1 2025: Strong start of the year and well-positioned for future grow…
|
English | 6.3 KB | |
| 2025-04-29 15:35 |
Regulatory News Service
Navamedic ASA: Imdur® distribution agreement extended to 2032
|
English | 3.5 KB | |
| 2025-04-28 14:44 |
Regulatory News Service
Navamedic ASA: Conclusion received from the Norwegian Financial Supervisory Aut…
|
English | 3.6 KB | |
| 2025-04-28 10:06 |
Regulatory News Service
Navamedic ASA: Invitation to 2025 1st quarter presentation
|
Norwegian | 1.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
|
Calliditas Therapeutics | Sweden | CALTX |